|
2024-10-09 |
2024-10-08 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
5,431
+169.3%
0.91
USD 4,942
|
5,431
+169.3%
|
0.91
|
USD 4,942
|
|
|
2023-09-28 |
2023-09-27 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+4.5%
1.02
USD 2,550
|
2,500
+4.5%
|
1.02
|
USD 2,550
|
|
|
2023-09-27 |
2023-09-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+4.7%
0.90
USD 2,250
|
2,500
+4.7%
|
0.90
|
USD 2,250
|
|
|
2023-04-27 |
2023-04-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,497
+27.2%
1.77
USD 2,650
|
1,497
+27.2%
|
1.77
|
USD 2,650
|
|
|
2023-04-26 |
2023-04-25 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,315
+31.3%
1.89
USD 2,485
|
1,315
+31.3%
|
1.89
|
USD 2,485
|
|
|
2022-07-27 |
2022-07-27 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+1.1%
0.38
USD 950
|
2,500
+1.1%
|
0.38
|
USD 950
|
|
|
2022-07-26 |
2022-07-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+1.1%
0.37
USD 935
|
2,500
+1.1%
|
0.37
|
USD 935
|
|
|
2022-07-26 |
2022-07-26 |
B
Purchase
|
Hamill John P.
SVP & CFO
Officer
|
3,000
+4.3%
0.37
USD 1,100
|
3,000
+4.3%
|
0.37
|
USD 1,100
|
|
|
2022-07-05 |
2022-06-30 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
4,500
+2.1%
0.43
USD 1,926
|
4,500
+2.1%
|
0.43
|
USD 1,926
|
|
|
2022-03-17 |
2022-03-16 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,000
+1.0%
0.98
USD 1,960
|
2,000
+1.0%
|
0.98
|
USD 1,960
|
|
|
2022-03-15 |
2022-03-15 |
B
Purchase
|
Simonson Steven
SVP, Chief Medical Officer
Officer
|
5,000
+6.4%
1.00
USD 4,999
|
5,000
+6.4%
|
1.00
|
USD 4,999
|
|
|
2022-03-15 |
2022-03-15 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+1.5%
0.98
USD 2,940
|
3,000
+1.5%
|
0.98
|
USD 2,940
|
|
|
2022-01-10 |
2021-12-30 |
S
Sale
|
Bioengine Capital Inc.
Large shareholder
|
1,239,088
-100.0%
1.60
USD 1,982,541
|
1,239,088
-100.0%
|
1.60
|
USD 1,982,541
|
|
|
2022-01-10 |
2021-12-30 |
B
Purchase
|
Center Laboratories, Inc.
Large shareholder
|
1,239,088
+inf%
1.60
USD 1,982,541
|
1,239,088
+inf%
|
1.60
|
USD 1,982,541
|
|
|
2021-11-22 |
2021-11-19 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
930
+2.5%
1.60
USD 1,488
|
930
+2.5%
|
1.60
|
USD 1,488
|
|
|
2021-11-18 |
2021-11-18 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
930
+2.6%
1.61
USD 1,497
|
930
+2.6%
|
1.61
|
USD 1,497
|
|
|
2021-10-25 |
2021-10-22 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+9.0%
1.90
USD 5,700
|
3,000
+9.0%
|
1.90
|
USD 5,700
|
|
|
2021-10-19 |
2021-10-19 |
B
Purchase
|
Huang James
Non-Executive Director
|
50,000
+20.7%
1.90
USD 95,135
|
50,000
+20.7%
|
1.90
|
USD 95,135
|
|
|
2021-10-19 |
2021-10-19 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+9.9%
1.91
USD 5,730
|
3,000
+9.9%
|
1.91
|
USD 5,730
|
|
|
2021-04-20 |
2021-04-16 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,000
+3.4%
2.09
USD 2,092
|
1,000
+3.4%
|
2.09
|
USD 2,092
|
|
|
2021-04-19 |
2021-04-15 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,000
+3.5%
2.24
USD 2,240
|
1,000
+3.5%
|
2.24
|
USD 2,240
|
|
|
2021-04-07 |
2021-04-06 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
500
+1.8%
2.57
USD 1,285
|
500
+1.8%
|
2.57
|
USD 1,285
|
|
|
2021-04-06 |
2021-04-05 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,000
+3.7%
2.58
USD 2,580
|
1,000
+3.7%
|
2.58
|
USD 2,580
|
|
|
2021-04-05 |
2021-04-01 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
500
+1.9%
2.46
USD 1,229
|
500
+1.9%
|
2.46
|
USD 1,229
|
|
|
2021-04-02 |
2021-03-31 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
150,000
+714.3%
2.36
USD 354,000
|
150,000
+714.3%
|
2.36
|
USD 354,000
|
|
|
2021-03-25 |
2021-03-25 |
B
Purchase
|
Hamill John P.
SVP & CFO
Officer
|
1,500
+150.0%
3.25
USD 4,875
|
1,500
+150.0%
|
3.25
|
USD 4,875
|
|
|
2021-03-25 |
2021-03-25 |
B
Purchase
|
Simonson Steven
SVP, Chief Medical Officer
Officer
|
1,500
+13.9%
3.25
USD 4,875
|
1,500
+13.9%
|
3.25
|
USD 4,875
|
|
|
2021-03-25 |
2021-03-25 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,500
+6.2%
3.25
USD 4,875
|
1,500
+6.2%
|
3.25
|
USD 4,875
|
|
|
2020-10-29 |
2020-10-28 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+1.0%
6.56
USD 1,640
|
250
+1.0%
|
6.56
|
USD 1,640
|
|
|
2020-10-27 |
2020-10-23 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
1,000
+5.0%
6.67
USD 6,666
|
1,000
+5.0%
|
6.67
|
USD 6,666
|
|
|
2020-10-13 |
2020-10-09 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+1.1%
5.83
USD 1,456
|
250
+1.1%
|
5.83
|
USD 1,456
|
|
|
2020-10-09 |
2020-10-08 |
B
Purchase
|
Curtis Eric
SVP & COO
Officer
|
500
+inf%
5.27
USD 2,635
|
500
+inf%
|
5.27
|
USD 2,635
|
|
|
2020-10-09 |
2020-10-07 |
B
Purchase
|
Hamill John P.
SVP & CFO
Officer
|
1,000
+inf%
5.27
USD 5,270
|
1,000
+inf%
|
5.27
|
USD 5,270
|
|
|
2020-10-09 |
2020-10-07 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+1.1%
5.17
USD 1,293
|
250
+1.1%
|
5.17
|
USD 1,293
|
|
|
2020-06-05 |
2020-06-04 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
12,200
+152.5%
7.32
USD 89,332
|
12,200
+152.5%
|
7.32
|
USD 89,332
|
|
|
2020-06-05 |
2020-06-03 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
200
+2.6%
7.42
USD 1,484
|
200
+2.6%
|
7.42
|
USD 1,484
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Tattory John A
SVP & CFO
Officer
|
449
+5.1%
7.25
USD 3,255
|
449
+5.1%
|
7.25
|
USD 3,255
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Schreiber Brian D
Non-Executive Director
|
2,069
+inf%
7.25
USD 15,000
|
2,069
+inf%
|
7.25
|
USD 15,000
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
PEACOCK BRUCE
Non-Executive Director
|
3,500
+65.0%
7.25
USD 25,375
|
3,500
+65.0%
|
7.25
|
USD 25,375
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Templeton Mary B Esq
SVP, Gen Counsel & Corp Sec
Officer
|
1,103
+3558.1%
7.25
USD 7,997
|
1,103
+3558.1%
|
7.25
|
USD 7,997
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
275,862
+13.4%
7.25
USD 2,000,000
|
275,862
+13.4%
|
7.25
|
USD 2,000,000
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Joseph Mahady M
Non-Executive Director
|
2,069
+38.4%
7.25
USD 15,000
|
2,069
+38.4%
|
7.25
|
USD 15,000
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Simonson Steven
SVP, Chief Medical Officer
Officer
|
517
+5.0%
7.25
USD 3,748
|
517
+5.0%
|
7.25
|
USD 3,748
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,069
+9.6%
7.25
USD 15,000
|
2,069
+9.6%
|
7.25
|
USD 15,000
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Leone John R
Non-Executive Director
|
2,069
+38.3%
7.25
USD 15,000
|
2,069
+38.3%
|
7.25
|
USD 15,000
|
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Geffken Daniel E.
Non-Executive Director
|
2,069
+inf%
7.25
USD 15,000
|
2,069
+inf%
|
7.25
|
USD 15,000
|
|
|
2022-01-10 |
2020-05-20 |
B
Purchase
|
Bioengine Capital Inc.
Large shareholder
|
55,172
+4.7%
7.25
USD 399,997
|
55,172
+4.7%
|
7.25
|
USD 399,997
|
|
|
2022-01-10 |
2020-05-20 |
B
Purchase
|
Center Laboratories, Inc.
Large shareholder
|
55,172
+4.7%
7.25
USD 399,997
|
55,172
+4.7%
|
7.25
|
USD 399,997
|
|
|
2020-02-20 |
2020-02-18 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
400
+1.7%
3.84
USD 1,535
|
400
+1.7%
|
3.84
|
USD 1,535
|
|
|
2020-02-12 |
2020-02-11 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+0.4%
4.10
USD 1,025
|
250
+0.4%
|
4.10
|
USD 1,025
|
|
|
2020-02-12 |
2020-02-10 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+0.4%
4.10
USD 1,025
|
250
+0.4%
|
4.10
|
USD 1,025
|
|
|
2020-02-07 |
2020-02-07 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
500
+2.2%
4.05
USD 2,025
|
500
+2.2%
|
4.05
|
USD 2,025
|
|
|
2020-02-05 |
2020-02-04 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
500
+0.8%
4.24
USD 2,120
|
500
+0.8%
|
4.24
|
USD 2,120
|
|
|
2020-02-05 |
2020-02-03 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
100
+0.2%
4.20
USD 420
|
100
+0.2%
|
4.20
|
USD 420
|
|
|
2020-01-21 |
2020-01-17 |
B
Purchase
|
Huang James
Large shareholder
|
2,000
+9.8%
4.18
USD 8,366
|
2,000
+9.8%
|
4.18
|
USD 8,366
|
|
|
2020-01-21 |
2020-01-16 |
B
Purchase
|
Huang James
Large shareholder
|
58
+0.3%
4.20
USD 244
|
58
+0.3%
|
4.20
|
USD 244
|
|
|
2020-01-03 |
2019-12-31 |
B
Purchase
|
Huang James
Large shareholder
|
15,442
+308.8%
4.05
USD 62,525
|
15,442
+308.8%
|
4.05
|
USD 62,525
|
|
|
2019-12-31 |
2019-12-30 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
909
+22.2%
3.81
USD 3,463
|
909
+22.2%
|
3.81
|
USD 3,463
|
|
|
2019-12-31 |
2019-12-27 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
4,091
+inf%
3.73
USD 15,261
|
4,091
+inf%
|
3.73
|
USD 15,261
|
|
|
2019-12-10 |
2019-12-06 |
B
Purchase
|
LPH II Investments Ltd
Large shareholder
|
1,655,629
+70.4%
3.02
USD 5,000,000
|
1,655,629
+70.4%
|
3.02
|
USD 5,000,000
|
|
|
2019-12-10 |
2019-12-06 |
B
Purchase
|
Huang James
Non-Executive Director
Large shareholder
|
1,655,629
+36.6%
3.02
USD 5,000,000
|
1,655,629
+36.6%
|
3.02
|
USD 5,000,000
|
|
|
2019-12-10 |
2019-12-06 |
B
Purchase
|
Lee's Pharmaceutical Holdings Ltd
Large shareholder
|
1,655,629
+12.9%
3.02
USD 5,000,000
|
1,655,629
+12.9%
|
3.02
|
USD 5,000,000
|
|
|
2018-04-06 |
2018-04-04 |
B
Purchase
|
Lee's Pharmaceutical Holdings Ltd
Large shareholder
|
541,667
+23.4%
4.80
USD 2,600,002
|
541,667
+23.4%
|
4.80
|
USD 2,600,002
|
|
|
2016-11-01 |
2016-10-28 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
7,500
+inf%
2.05
USD 15,381
|
7,500
+inf%
|
2.05
|
USD 15,381
|
|
|
2013-02-20 |
2013-02-19 |
B
Purchase
|
Leone John R
Non-Executive Director
|
3,000
+inf%
2.88
USD 8,640
|
3,000
+inf%
|
2.88
|
USD 8,640
|
|
|
2010-12-21 |
2010-12-17 |
S
Sale
|
LOPEZ DAVID L
Executive VP & Legal Counsel
Officer
|
16,300
-5.9%
0.21
USD 3,449
|
16,300
-5.9%
|
0.21
|
USD 3,449
|
|
|
2010-12-21 |
2010-12-17 |
S
Sale
|
LOPEZ DAVID L
Executive VP & Legal Counsel
Officer
|
700
-0.3%
0.21
USD 148
|
700
-0.3%
|
0.21
|
USD 148
|
|
|
2008-11-20 |
2008-11-20 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
14,674
+7.0%
0.90
USD 13,133
|
14,674
+7.0%
|
0.90
|
USD 13,133
|
|
|
2008-11-20 |
2008-11-20 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
500
+0.4%
0.91
USD 453
|
500
+0.4%
|
0.91
|
USD 453
|
|
|
2008-11-20 |
2008-11-19 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
9,655
+4.8%
0.93
USD 8,979
|
9,655
+4.8%
|
0.93
|
USD 8,979
|
|
|
2008-11-20 |
2008-11-19 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
23,400
+23.1%
0.93
USD 21,762
|
23,400
+23.1%
|
0.93
|
USD 21,762
|
|
|
2008-11-20 |
2008-11-18 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
25,671
+14.7%
1.00
USD 25,671
|
25,671
+14.7%
|
1.00
|
USD 25,671
|
|
|
2008-11-20 |
2008-11-18 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
1,100
+1.1%
1.00
USD 1,100
|
1,100
+1.1%
|
1.00
|
USD 1,100
|
|
|
2008-11-17 |
2008-11-17 |
B
Purchase
|
CAPETOLA ROBERT J
President/CEO
Executive Director
|
40,000
+10.1%
1.01
USD 40,400
|
40,000
+10.1%
|
1.01
|
USD 40,400
|
|
|
2008-11-17 |
2008-11-17 |
B
Purchase
|
CAPETOLA ROBERT J
President/CEO
Executive Director
|
10,000
+2.3%
1.05
USD 10,450
|
10,000
+2.3%
|
1.05
|
USD 10,450
|
|
